Please use this identifier to cite or link to this item:
10.2478/prolas-2021-0015
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Trapp, Maximiliane | - |
dc.contributor.author | Mihailova, Anna | - |
dc.contributor.author | Kakurina, Natalija | - |
dc.contributor.author | Murovska, Modra | - |
dc.date.accessioned | 2021-10-21T10:25:01Z | - |
dc.date.available | 2021-10-21T10:25:01Z | - |
dc.date.issued | 2021-04-01 | - |
dc.identifier.citation | Trapp , M , Mihailova , A , Kakurina , N & Murovska , M 2021 , ' Significance of hypouricaemia in the development of neurodegenerative diseases ' , Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences , vol. 75 , no. 2 , pp. 92-98 . https://doi.org/10.2478/prolas-2021-0015 | - |
dc.identifier.issn | 2255-890X | - |
dc.identifier.uri | https://dspace.rsu.lv/jspui/handle/123456789/6696 | - |
dc.description | Publisher Copyright: © 2021 Sciendo. All rights reserved. | - |
dc.description.abstract | Hypouricaemia has received relatively little attention in the literature. As a result, there is lessawareness or understanding of the potential risks of low uric acid levels. Emerging research indi-cates that normal uric acid levels may have an antioxidative and neuroprotective effect. Thisstudy aims to investigate possible associations between hypouricaemia and neurodegenerativedisease. Data was collected from seventy-seven outpatients and inpatients who underwent rou-tine uric acid testing, who were then stratified into patients with and without neurodegenerativedisease. Patients with renal pathologies and patients using uric acid altering medications were ex-cluded from the study. There was a significant difference in the prevalence of Alzheimer’s diseasebetween hypouricemic and normouricemic patients (p= 0.001), however there was no differencein the prevalence of vascular dementia (p= 0.45). This study provides evidence that hypouricae-mia has potential effects on health, specifically on the rate of neurodegenerative diseases suchas Alzheimer’s disease and gives weight to the potential neuroprotective role of uric acid. | en |
dc.format.extent | 7 | - |
dc.format.extent | 190370 | - |
dc.language.iso | eng | - |
dc.relation.ispartof | Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.subject | uric acid, Alzheimer’s disease, vascular dementia | - |
dc.subject | 3.2 Clinical medicine | - |
dc.subject | 1.1. Scientific article indexed in Web of Science and/or Scopus database | - |
dc.title | Significance of hypouricaemia in the development of neurodegenerative diseases | en |
dc.type | /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article | - |
dc.identifier.doi | 10.2478/prolas-2021-0015 | - |
dc.contributor.institution | Faculty of Medicine | - |
dc.contributor.institution | Institute of Microbiology and Virology | - |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85106290705&partnerID=8YFLogxK | - |
dc.description.status | Peer reviewed | - |
Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Significance_of_hypouricaemia_in_the_development_of_neurodegenerative_diseases.pdf | 185.91 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.